Evidence map›Paper›PMID 24595055›Full record

ArticlePloS one2014

Casein kinase II induced polymerization of soluble TDP-43 into filaments is inhibited by heat shock proteins.

Yari Carlomagno, Yongjie Zhang, Mary Davis, Wen-Lang Lin, Casey Cook, Judy Dunmore, William Tay, Kyle Menkosky, Xiangkun Cao, Leonard Petrucelli and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. AnAnnals of medicine · 2023
    Article
  10. Big versus small: The impact of aggregate size in disease.Protein science : a publication of the Protein Society · 2023
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

11 authors.

Yari CarlomagnoDepartment of Neuroscience, Maya Clinic, Jacksonville, Florida, United States of America.
Yongjie ZhangDepartment of Neuroscience, Maya Clinic, Jacksonville, Florida, United States of America.
Mary DavisDepartment of Neuroscience, Maya Clinic, Jacksonville, Florida, United States of America.
Wen-Lang LinDepartment of Neuroscience, Maya Clinic, Jacksonville, Florida, United States of America.
Casey CookDepartment of Neuroscience, Maya Clinic, Jacksonville, Florida, United States of America.
Judy DunmoreDepartment of Neuroscience, Maya Clinic, Jacksonville, Florida, United States of America.
William TayDepartment of Neuroscience, Maya Clinic, Jacksonville, Florida, United States of America.
Kyle MenkoskyDepartment of Neuroscience, Maya Clinic, Jacksonville, Florida, United States of America.
Xiangkun CaoDepartment of Neuroscience, Maya Clinic, Jacksonville, Florida, United States of America.
Leonard PetrucelliDepartment of Neuroscience, Maya Clinic, Jacksonville, Florida, United States of America.
Michael DetureDepartment of Neuroscience, Maya Clinic, Jacksonville, Florida, United States of America.

Funding

Stress Granules and the Biology of TDP-43R01ES020395 · NIEHS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WOLOZIN, BENJAMIN L · 2012 to 2016
$4.1M
TDP-43, RNA Metabolism, and ALS/FTD PathologyR01NS063964 · NINDS · UNIVERSITY OF COLORADO · PI LINK, CHRISTOPHER D. · 2009 to 2019
$3.5M
The genetics of chromosome 17q21-linked tau-negative FTDR01AG026251 · NIA · MAYO CLINIC JACKSONVILLE · PI PETRUCELLI, LEONARD · 2006 to 2014
$1.9M
Misregulation of the TDP-43 RNA target, Sortilin, in neurodegenerationR01NS077402 · NINDS · MAYO CLINIC JACKSONVILLE · PI PETRUCELLI, LEONARD · 2011 to 2015
$1.7M
Understanding the Mechanisms of TDP-43 FunctionR21NS079807 · NINDS · MAYO CLINIC JACKSONVILLE · PI FRYER, JOHN DAVID, ZHANG, YONGJIE · 2013 to 2014
$428k
NIA NIH HHS R01 AG026251NIA NIH HHS R01AG026251NIEHS NIH HHS ES20395-01NIEHS NIH HHS R01 ES020395NINDS NIH HHS 1R21NS079807-01A1NINDS NIH HHS R01 NS063964NINDS NIH HHS R01 NS 063964-01NINDS NIH HHS R01 NS077402NINDS NIH HHS R21 NS079807
6 · The paper itself

Abstract

backgroundTrans-activation Response DNA-binding Protein-43 (TDP-43) lesions are observed in Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Lobar Degeneration with ubiquitin inclusions (FTLD-TDP) and 25-50% of Alzheimer's Disease (AD) cases. These abnormal protein inclusions are composed of either amorphous TDP-43 aggregates or highly ordered filaments. The filamentous TDP-43 accumulations typically contain clean 10-12 nm filaments though wider 18-20 nm coated filaments may be observed. The TDP-43 present within these lesions is phosphorylated, truncated and ubiquitinated, and these modifications appear to be abnormal as they are linked to both a cellular heat shock response and microglial activation. The mechanisms associated with this abnormal TDP-43 accumulation are believed to result in a loss of TDP-43 function, perhaps due to the post-translational modifications or resulting from physical sequestration of the TDP-43. The formation of TDP-43 inclusions involves cellular translocation and conversion of TDP-43 into fibrillogenic forms, but the ability of these accumulations to sequester normal TDP-43 and propagate this behavior between neurons pathologically is mostly inferred. The lack of methodology to produce soluble full length TDP-43 and recapitulate this polymerization into filaments as observed in disease has limited our understanding of these pathogenic cascades.

resultsThe protocols described here generate soluble, full-length and untagged TDP-43 allowing for a direct assessment of the impact of various posttranslational modifications on TDP-43 function. We demonstrate that Casein Kinase II (CKII) promotes the polymerization of this soluble TDP-43 into 10 nm diameter filaments that resemble the most common TDP-43 structures observed in disease. Furthermore, these filaments are recognized as abnormal by Heat Shock Proteins (HSPs) which can inhibit TDP-43 polymerization or directly promote TDP-43 filament depolymerization.

conclusionThese findings demonstrate CKII induces polymerization of soluble TDP-43 into filaments and Hsp90 promotes TDP-43 filament depolymerization. These findings provide rational for potential therapeutic intervention at these points in TDP-43 proteinopathies.

Indexed as

AnimalsCasein Kinase IIDNA-Binding ProteinsFrontotemporal Lobar DegenerationHSP90 Heat-Shock ProteinsHumansInclusion BodiesMicePhosphorylationPolymerizationProtein Aggregation, PathologicalReproducibility of ResultsSolubilityCasein Kinase IIDNA-Binding ProteinsHSP90 Heat-Shock Proteins

Identifiers

PMID24595055
PMCPMC3942448
OpenAlexW2047943797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.